Jennison Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,763,258
| Closed | -$90M | – | 645 |
|
|
2024
Q4 | $90M | Buy |
1,763,258
+186,617
| +12% | +$9.17M | 0.05% | 148 |
|
|
2024
Q3 | $65M | Buy |
1,576,641
+610,468
| +63% | +$29.3M | 0.04% | 183 |
|
|
2024
Q2 | $46.5M | Buy |
966,173
+622,734
| +181% | +$27.6M | 0.03% | 220 |
|
|
2024
Q1 | $16.5M | Sell |
343,439
-100,070
| -23% | -$5.35M | 0.01% | 358 |
|
|
2023
Q4 | $28.8M | Buy |
443,509
+33,419
| +8% | +$2.01M | 0.02% | 283 |
|
|
2023
Q3 | $26.8M | Sell |
410,090
-110,606
| -21% | -$6.96M | 0.02% | 273 |
|
|
2023
Q2 | $30.3M | Sell |
520,696
-67,573
| -11% | -$4.26M | 0.02% | 263 |
|
|
2023
Q1 | $36.3M | Buy |
588,269
+79,279
| +16% | +$4.76M | 0.03% | 231 |
|
|
2022
Q4 | $32.4M | Buy |
508,990
+102,953
| +25% | +$7.47M | 0.03% | 258 |
|
|
2022
Q3 | $29.5M | Sell |
406,037
-107,321
| -21% | -$7.99M | 0.03% | 260 |
|
|
2022
Q2 | $34.9M | Sell |
513,358
-290,589
| -36% | -$20.9M | 0.03% | 224 |
|
|
2022
Q1 | $72.9M | Buy |
803,947
+48,470
| +6% | +$3.97M | 0.05% | 154 |
|
|
2021
Q4 | $69M | Buy |
755,477
+480,150
| +174% | +$41.1M | 0.04% | 173 |
|
|
2021
Q3 | $22.3M | Buy |
+275,327
| New | +$23.1M | 0.01% | 347 |
|
|
2020
Q3 | – | Sell |
-44,733
| Closed | -$2.17M | – | 698 |
|
|
2020
Q2 | $2.17M | Buy |
+44,733
| New | +$2.14M | ﹤0.01% | 465 |
|
Other funds holding NARI
SA
IA
TCWM
PS